Mucosal humoral immune response to CagA shows a high prevalence in patients with gastric MALT-type lymphoma

Virchows Archiv

Volumn 436, Issue 2, 2000, Pages 115-118

  Schmaußer, Bernd ^a   Eck, Matthias ^a   Greiner, Axel ^a   Kraus, Michael ^a   Müller Hermelink, Hans Konrad ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

CagA; Helicobacter pylori; MALT type lymphoma; Mucosal immune response

Indexed keywords

BACTERIAL ANTIGEN;

ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; GASTRITIS; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; MONONUCLEAR CELL; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MUCOSAL IMMUNITY; PATHOGENESIS; PRIORITY JOURNAL; STOMACH LYMPHOMA;

EID: 0034010280     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00008209     Document Type: Article

References (13)

1. 1. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A (1995) Infection with Helicobacter pylori strains possessing cagA is associated with an increase of developing adenocarcinoma of the stomach. Cancer Res 55:2111-2115
2. 2. Crabtree JE, Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, Tompkins DS, Rathbone BJ (1991) Mucosal IgA recognition of Helicobacter pylori 120 kD protein, peptic ulceration and gastric pathology. Lancet 338:332-335
3. 3. De Jong D, Rene WM, van der Hulst, Pals G, van Dijk WC, van der Ende A, Tytgat GN, Taal BG, Boot H (1996) Gastric Non-Hodgkin lymphomas of mucosa-associated lymphoid tissue are not associated with more aggressive Helicobacter pylori strains as identified by CagA. Am J Clin Pathol 106: 670-675
4. 4. Elios MM, Manghetti M, De Carli M, Costa F, Baldari CT, Burroni D, Telford JL, Romagnani S, Del Prete G (1997) T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J Immunol 158:962-967
5. 5. Eck M, Schmaußer B, Haas R, Greiner A, Czub S, Müller-Hermelink HK (1997) MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing CagA protein. Gastroenterology 112:1482-1486
6. 6. Greiner A, Müller-Hermelink HK (1996) Recent advances in gastric extranodal B cell lymphoma. Curr Diagn Pathol 3: 307-319
7. 7. Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orentreich N, Vogelmann JH, Friedman GD (1994) Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330:1267-1271
8. 8. Parsonett J, Friedman GD, Orentreich N, Vogelman H (1997) Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 40:297-301
9. 9. Weel JFL, van der Hulst RWM, Gerritis Y, Roorda P, Feller M, Dankert J, Tytgat GN, van der Ende A (1996) The interrelationship between cytotoxin associated gene A, vacuolating cytotoxin and Helicobacter pylori related diseases. J Infect Dis 173:1171-1175
10. - Helicobacter pylori infection. J Infect Dis 176:1641-1644
11. 11. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG (1991) Helicobacter pylori-asssociated gastritis and primary B-cell gastric lymphoma. Lancet 338:1175-1176
12. 12. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG (1993) Regression of primary low-grade B-cell gastrointestinal lymphoma of mucosa associated lymphoid tissue after eradication of Helicobacter pylori. Lancet 342:575-577
13. 13. Xiang Z, Censini S, Bayelli PF, Telford JL, Figura N, Rappuoli R, Covacci C (1995) Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for the expression of vacuolating cytotoxin. Infect Immun 63:94-98